Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets - Wikidata - wikimedia - TriplyDB

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

http://www.wikidata.org/entity/Q35747448

about

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas Update on molecular findings, management and outcome in low-grade gliomas.BTECH: a platform to integrate genomic, transcriptomic and epigenomic alterations in brain tumors Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging.Advanced MRI in the management of adult gliomas.Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours.Prognostic stratification of patients with anaplastic gliomas according to genetic profile.Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.Biology, genetics and imaging of glial cell tumours Molecular classification of low-grade diffuse gliomas.The WNKs: atypical protein kinases with pleiotropic actions.DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.Genome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: facilitating analysis of archival gliomas.Analysis of the IDH1 codon 132 mutation in brain tumors.Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas.Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.Oligodendrogliomas: an update on basic and clinical research.Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.Pathology and molecular genetics of oligodendroglial tumors.Incidence of gliomas by anatomic location.Molecular pathogenesis of oligodendroglial tumors.Genetic markers in oligodendroglial tumours.The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.The evolution of mathematical modeling of glioma proliferation and invasion.Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.Correlation of histomorphologic prognostic markers and proliferative index with loss of heterozygosity 1p/19q and MGMT status in diffusely infiltrating gliomas.Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system.Molecular genetics, imaging and treatment of oligodendroglial tumours.Genetic profile of astrocytic and oligodendroglial gliomas.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.The role of surgery in grade II/III oligodendroglial tumors.Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.

P2860

Q24656269-59E079A7-15DA-4BC2-8414-4C7A7E2CA082 Q24816392-27548BC1-A740-49CC-8B60-5CA173669AE3 Q30452178-1FC56122-6C1B-440A-B0B4-462785D9190E Q30484798-70D933D4-CA8F-4D07-8320-132373112A62 Q30998879-0D2CDB8E-C562-4E7A-9081-CE0BD0E9D895 Q31139548-62E4E53D-86F8-4465-B982-BF394A4A3058 Q33232891-7018CCCE-A125-45CF-BFE1-BEE3C964E25A Q33258125-0CA6E977-A7B3-4897-A144-A39F8C785AA4 Q33410196-E617411B-BC5F-4C9D-9BB2-120042BEA214 Q33784207-0D4C9277-B539-4F3B-AB96-A462F8A35916 Q33938833-1DA97905-71AC-4157-91B0-92C00D636471 Q34062043-2525CC8B-54DD-4DB3-A616-3CED929F2B65 Q34200021-9CB5EB0B-D447-4645-BFDF-7F64D4F8C4E5 Q34203979-D96A3593-8E43-4DFD-883A-52229F0B7B71 Q34358250-2FEFBF22-9DB0-49B6-9576-B3FDBE99B1F9 Q34560188-3AEC7356-0B89-4450-8D1B-EBC52B5C5692 Q34645950-5CA261DE-5F9B-43E9-B4D9-64F64B3107D2 Q34687243-0EBA0808-54F7-4B9E-820A-6A3C2C7F08B8 Q34873009-A02790A8-96F9-44FE-97C8-C6CCEF61ABA1 Q35038503-703F8E3F-633B-4E46-A28A-13642CCC2820 Q35063647-4EAAE657-69B5-4934-A912-9955B9A920E8 Q35105809-FBAF2534-3B51-4C0B-B14F-39F7F637088C Q35792015-D0089C8F-FE14-4C3C-A621-FE905D4C3313 Q35864945-C7D8F12C-7684-44EF-91B7-D9556897F84E Q35868124-E7C227B9-B992-4668-AA4B-38FB9C104290 Q35870508-C3DE45F4-7DDB-4BED-8656-9D0085E10874 Q36021563-27A179BF-62F1-466B-8BD4-49605AA72C9E Q36177607-406BBAF1-8DA2-4F97-9D44-5ADEA0ED867B Q36516449-AAA1A378-9EE0-4B04-874F-17B87E0CFE51 Q36699985-78576A0E-4B55-41DD-9321-C40CAD88C696 Q37350203-16696026-2F65-462B-A6A3-661E78A32DC9 Q37390680-06B783B5-E200-4844-8A06-2001EAF37423 Q37409721-0F477CDF-8CFF-44B3-B01D-70AB9C0F662E Q37746324-7E57075F-B407-4016-8C83-1B255C9BE452 Q37784709-48B3902D-39A9-42F3-BF95-9E5A37F48C1B Q37858440-1F67972E-7DBE-4E49-83ED-3F33BFA7B480 Q38108186-7CDA1A77-8195-40BE-A46A-CC0F1103ED78 Q38610485-46F44BAA-E483-467C-B1B2-71ABBE47FD7D Q40109714-9D319EBC-15BE-42AF-B4E5-9D1B47DB8620 Q40231438-460B2E41-0941-4D93-8606-1F69716204AA

P2860

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

http://www.wikidata.org/entity/Q35747448

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Genetic signature of oligoastr ...... tes distinct molecular subsets

@ast

Genetic signature of oligoastr ...... tes distinct molecular subsets

@en

type

label

Genetic signature of oligoastr ...... tes distinct molecular subsets

@ast

Genetic signature of oligoastr ...... tes distinct molecular subsets

@en

prefLabel

Genetic signature of oligoastr ...... tes distinct molecular subsets

@ast

Genetic signature of oligoastr ...... tes distinct molecular subsets

@en

P1433

Q35747448-4F740ACE-0E6C-4E39-9B49-406D8BC4515D

P1476

Q35747448-5E116479-CAF6-4E6B-A21E-8B7D999238E7

P2093

Q35747448-1BA2A47F-9EE7-404B-BDCB-B8C6EEAA29C0

Q35747448-2176C642-7FFD-41C4-BEE7-341661180C9F

Q35747448-28677472-6E56-4013-AF5C-10F22FF4B6A4

Q35747448-4604FE8F-F56A-457D-AEFB-F36D0131A443

Q35747448-49E529EA-EBB5-48B6-A885-F1669A11E4C3

Q35747448-619877F5-D952-4247-882B-59F917B2F510

Q35747448-7485C4FE-C79F-49AD-827E-4ACF50C12349

Q35747448-A514F10E-AB50-4D68-A36A-81673AC111FF

Q35747448-BD854A03-EB8B-44AE-9613-64A006FBE530

Q35747448-DF192A03-464A-4A62-BC01-20EDF41CD7BB

P2860

Q35747448-05987D25-1284-42C1-A21A-AE62C61AC5B8

Q35747448-1011B53C-043E-4F6A-BEAD-8E2D256B1BEC

Q35747448-2020ED06-DC1D-4A55-93A1-83E06C4A5CBE

Q35747448-2058AA57-418F-4997-A1A6-028D18DBA7CD

Q35747448-206B1A9F-77EF-4814-882A-D470344E8402

Q35747448-27927E3E-2998-46C0-BF0F-3A24F0F97A81

Q35747448-317EA4B8-ADB1-400B-8AA0-8F17130AF093

Q35747448-33033643-495C-4C69-93A5-8404F82FA9CE

Q35747448-3692680D-309D-4F40-BC67-44AB10855C85

Q35747448-38382312-35FB-4030-A489-9FDE9C2EE989

P304

Q35747448-C98662A0-0C0B-4509-85AB-DB8687A7D1DF

P31

Q35747448-3DAD6EE1-8F70-4ADD-97B5-5F6A58EB4C7D

P356

Q35747448-0AFC8D1C-7CAC-49F8-9B88-057FBE64F1CA

P407

Q35747448-E0B74935-2E92-43B5-8616-C1B4C2424A48

P433

Q35747448-87EFC50C-7AD0-4F30-AEAF-C2E397298E9E

P478

Q35747448-AE48F076-4F82-4492-B18C-1E64E902F927

P50

Q35747448-0B80B7BB-CCF8-4223-B8B5-5CB58D072C28

Q35747448-F3F2468D-D3EA-4033-8339-8DD86D1185FB

P577

Q35747448-509FBF53-EBA5-4576-9B98-CDAC6F39E884

P5875

Q35747448-97543E56-A531-468B-BA58-73FD51EC6D8F

P698

Q35747448-BA717439-026D-485D-A907-B16FA727A4B8

P932

Q35747448-979A82E1-CA16-4D86-99AC-AB3D23B34E16

P356

S0002-9440(10)64183-1

P1433

The American Journal of Pathology

P1476

Genetic signature of oligoastr ...... tes distinct molecular subsets

@en

P2093

Annegret Hoffmann

http://www.w3.org/2001/XMLSchema#string

Christian Hartmann

http://www.w3.org/2001/XMLSchema#string

David N Louis

http://www.w3.org/2001/XMLSchema#string

Johannes Schramm

http://www.w3.org/2001/XMLSchema#string

Julian Veelken

http://www.w3.org/2001/XMLSchema#string

Jörg Tonn

http://www.w3.org/2001/XMLSchema#string

Jürgen Kiwit

http://www.w3.org/2001/XMLSchema#string

Otmar D Wiestler

http://www.w3.org/2001/XMLSchema#string

Wolf Mueller

http://www.w3.org/2001/XMLSchema#string

Wolfgang Lanksch

http://www.w3.org/2001/XMLSchema#string

P2860

p53 mutations in nonastrocytic human brain tumors

Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.

Single or multiple oligodendroglial lineages: a controversy.

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Glioma classification: a molecular reappraisal.

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens.

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

P304

313-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64183-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P50

Andreas von Deimling

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11271560

http://www.w3.org/2001/XMLSchema#string

P698

12107116

http://www.w3.org/2001/XMLSchema#string

P932

1850690

http://www.w3.org/2001/XMLSchema#string